# A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

> **NCT00046332** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 100 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** GW810781

## Key facts

- **NCT ID:** NCT00046332
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2003-01
- **Final completion:** 2003-01
- **Target enrollment:** 100 (—)
- **Last updated:** 2013-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046332, "A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00046332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*